Giulia Kennedy, Jessica Meng

Veracyte said that it is consolidating its clinical, medical, and R&D functions into one department, which will be headed by Giulia Kennedy, who has served as CSO since the company's founding in 2008. The company also appointed Jessica Meng as vice president of marketing. Meng joins Veracyte from Genentech where she led marketing for Avastin in oncology.